CHRNB2 and colorectal cancer: These findings suggest that CHRNB2 plays a critical role in the malignant phenotype associated with peritoneal dissemination and may serve as a promising target for therapeutic intervention in colorectal cancer patients with or at risk for peritoneal metastasis.